SNNAQ

$0.00+$0.00 (+0.00%)prev close

Held by

portfolios on TandT

Bookmarked by

users

Avg position size

—

of holders' portfolios

13F filers

institutions

52-week range

$0.00 – $0.00

0% from low

Exchange

OTC Link

Change+$0.00

Earnings surprises

Beat consensus in 2 of the last 7 reported quarters

Reported	Est. EPS	Actual	Surprise
2019-11-12	$-0.24	$-0.13	+45.8%
2019-08-08	$-0.40	$-0.27	+32.5%
2019-05-08	$-0.50	$-0.63	-26.0%
2019-03-14	$-0.83	$-0.93	-12.0%
2018-11-08	$-0.79	$-0.82	-3.8%
2018-08-09	$-0.79	$-1.00	-26.6%
2018-05-14	$-0.71	$-0.85	-19.7%

Intrinsic value

$0.77

Price

$0.00

Implied upside

+76891851%

Symbol	Price	Today	Mkt cap	P/E
SNNAQSienna Biopharmaceuticals, Inc.	$0.00	+0.00%	$3091	—
ADYXAdynxx, Inc.	$0.00	+0.00%	$581	—
AZTRAzitra, Inc.	$0.14	-1.86%	$1M	—
CRNXCrinetics Pharmaceuticals, Inc.	$84.62	+0.21%	$9.0B	—
HALOHalozyme Therapeutics, Inc.	$98.46	-2.20%

No one on the platform currently holds SNNAQ.

Institutions holding (13F)

No tracked institution reports a position in SNNAQ as of their last filing.

Insider activity (SEC Form 4)

No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.

Insider activity (SEC Form 4)

No one on the platform has traded SNNAQ yet.